Home • Industry Projects • Galida - Dual PPAR Agonist for Type 2 Diabetes and Metabolic Syndrome • Image 1

The US NCEP Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol ATP III criteria are among the most widely used for diagnosis of metabolic syndrome.

		Next»

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |